DEA warns that ADHD over prescription could be as bad as opioid crisis

The DEA has expressed concerns to ADHD medication manufacturers that 'aggressive marketing practices' may be contributing to excessive prescriptions.

Related Keywords

United States ,America ,Kristi Omalley ,Instagram ,Diversion Control Division ,Done Global Inc ,Drug Enforcement Administration ,Facebook ,Cerebral Inc ,Wall Street ,Drug Administration ,Kristio Malley ,Dailymail ,News ,Adhd ,